The startup aims to provide every life sciences expert with their team of intelligent agents, reducing response timelines for ...

The head of the EU's pharmaceutical lobby has called for the creation of a life sciences-focused stock market in Europe, ...

The company is hoping to become the next CSL, but stood its workforce down in November amid a cash crunch. A lifeline now ...

Hong Kong is on track to become the world’s largest listing destination this year, surpassing the Nasdaq and the New York ...

Even the CEOs of Big Pharmas have come under fire. Activist investor Starboard Value has made no secret of its criticism of Pfizer CEO Albert Bourla’s track record, while GSK CEO Emma Walmsley fought ...

Building blocks for flexible bioprocessing must also be easy to install and take little time to train operators.

The scheme is aimed at fostering local innovation and reducing reliance on foreign patents. It targets diverse industries, ...

Hong Kong shares fell on Thursday, led by tech stocks, as investors fretted that intensifying competition among e-commerce ...

INmune Bio's XPro shows promise in early AD despite missed endpoints. Click here to find out why I rate INMB stock is a Hold.

A new investing playbook is required for older Americans, who are living and working longer. Meanwhile, investors in general ...

"Ligand has been an incredible partner over the past few years, and we look forward to their continued guidance and support ...

Arbele Limited, a Hong Kong-based biotech company, was awarded first place at the 4th Biomedical Pitch Competition, hosted by the Boston Capital Investment Club (BCIC). Selected from over 170 ...